Roche reportedly pursuing buyout of genomics company Pacific Biosciences of California

Shares of Menlo Park's Pacific Biosciences ($PACB) of California are up 25% on a report that Big Pharma (and diagnostics) player Roche ($RHHBY) is interested in acquiring the provider of gene sequencing technology. The company makes the Sequel System for single-molecule, real-time sequencing. More

Suggested Articles

Medtronic's new data shows its catheter-based ablation procedure, aimed at the kidneys, can help lower high blood pressure where drugs have failed.

At the two-year mark, the data show TAVR and open surgery patients are equivalent when it comes to risks of stroke, hospitalization and death.

Abbott launched a rapid coronavirus test able to deliver positive results in as little as five minutes from a tabletop box the size of a toaster.